Entrada Therapeutics

Developer of the biologics-based platform to treat rare diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups122 employees language entradatx.com

Registered entities

Social engagement

Social engagement: 35.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Wellington, 5AM Ventures, MRLV, Roche.

Investor typeCountShare
Venture capital646%
Private equity18%
Bank & private debt18%
Other / undisclosed538%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

5 Jul 2025 · Associate Director, Biosample Operations · Boston

16 Jun 2025 · Administrative & Events Associate · Boston

13 Jun 2025 · Administrative & Events Associate · Boston

12 Jun 2025 · Study Start Up Lead (CONTRACT) · Boston

25 Jan 2025 · Contracts Specialist · Boston

Based on job postings tracked across public sources.

Recent activity

2 Jul 2026
Event
19th International Congress on Neuromuscular Diseases - ICNMD
17 Jun 2026
Event
Parent Project Muscular Dystrophy's 2026 Annual Conference
Coming soon